Dr. Paul Peter Tak is a physician-scientist and professor who served as Chief Immunology Officer at GSK. He currently leads Candel Therapeutics as CEO, driving innovation in immunology and therapeutic development. Based in Needham, MA, Dr. Tak combines scientific expertise with executive leadership in the biotechnology sector.

‌